Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Colombiana de Reumatología
Print version ISSN 0121-8123
Abstract
SALDARRIAGA RIVERA, Lina María; MARIN GIRALDO, Christian David and HERNANDEZ VELASCO, Fabián Andrés. Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report. Rev.Colomb.Reumatol. [online]. 2023, vol.30, n.2, pp.162-165. Epub May 16, 2024. ISSN 0121-8123. https://doi.org/10.1016/j.rcreu.2021.05.016.
Alopecia areata (AA) is an autoimmune disease that generates non-scar loss of hair with varying degrees of involvement, including total loss of hair follicles. Despite being a benign entity, it has a great impact on the emotional and psychosocial life of patients. A wide variety of topical and oral treatments are currently available. We present the case of a 24-year-old patient with severe recurrent alopecia areata without response to multiple pre vious treatments, in which a secondary cause was ruled out and the histological diagnosis was confirmed with biopsy. Treatment with tofacitinib, a JAK inhibitor, was started, showing an excellent clinical response after one month of treatment.
Keywords : Alopecia areata; Tofacitinib; Janus kinase.